Utility of Expedited Hereditary Cancer Testing in the Surgical Management of Patients with a New Breast Cancer Diagnosis
Kristin A. Theobald(GenVec), Benjamin D. Solomon(National Human Genome Research Institute), Ravin N. W. Williams, Darrow Speyer, Lisa R. Susswein, Maegan E. Roberts, Kathleen S. Hruska, Megan L. Marshall(St Mark's Hospital), Jessica L. Mester(West Coast University), Patricia D. Murphy(Newark Beth Israel Medical Center), Sheila Solomon, Rachel T. Klein, Sara Knapke
Cited by 10
Related Papers
The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.
|PubMed|1989|963
Sequencing Chromosomal Abnormalities Reveals Neurodevelopmental Loci that Confer Risk across Diagnostic Boundaries
|Cell|2012|598
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
|Genetics in Medicine|2015|292
Germline Genetic Testing After Cancer Diagnosis
|JAMA|2023|160